Mirae Asset Global Investments’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-5,314
| Closed | -$255K | – | 2569 |
|
2022
Q3 | $255K | Buy |
5,314
+1,537
| +41% | +$73.8K | ﹤0.01% | 2234 |
|
2022
Q2 | $215K | Buy |
+3,777
| New | +$215K | ﹤0.01% | 2127 |
|
2019
Q3 | – | Sell |
-451
| Closed | -$240K | – | 1452 |
|
2019
Q2 | $240K | Sell |
451
-69
| -13% | -$36.7K | ﹤0.01% | 1331 |
|
2019
Q1 | $262K | Buy |
+520
| New | +$262K | ﹤0.01% | 1220 |
|
2018
Q4 | – | Sell |
-514
| Closed | -$470K | – | 1326 |
|
2018
Q3 | $470K | Sell |
514
-743
| -59% | -$679K | ﹤0.01% | 1046 |
|
2018
Q2 | $921K | Sell |
1,257
-206
| -14% | -$151K | 0.01% | 525 |
|
2018
Q1 | $2.33M | Buy |
+1,463
| New | +$2.33M | 0.03% | 339 |
|
2016
Q4 | – | Sell |
-1,506
| Closed | -$388K | – | 545 |
|
2016
Q3 | $388K | Buy |
+1,506
| New | +$388K | 0.01% | 472 |
|